You are here

Entheon Biomedical Corp.

Entheon Biomedical Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
ENBI
CSE Index: 
Currency: 

Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders. 

You are here

Entheon Biomedical Corp. (ENBI)

SEDAR Information

Company Info

Address
Suite 720-999 W Broadway Street
Vancouver, BC V5Z 1K5
Canada
Phone
604-562-3932
Email
[email protected]
Website
https://entheonbiomedical.com/
Listing date
Thursday, May 3, 2018
Transfer Agent
Olympia Trust Company
Auditor
Manning Elliott LLP

Capitalization

Issued & Outstanding: 
59,089,266
Reserved for Issuance: 
3,450,000

Company Officers

Timothy Ko, CEO
Soo-Whan Kim, Interim CFO
Kelly Pladson, Corporate Secretary

Bulletins

11/11/2020

2020-1111 – Fundamental Change - MPV Explorations Inc./Entheon Biomedical Corp.

le 11 novembre/November 2020

Entheon Biomedical Corp., the issuer resulting from a Fundamental Change of MPV Explorations Inc. (MPV), has been approved for listing.

Listing and disclosure documents will be available at www.thecse.com on the trading date.